Heart Failure, Sudden Cardiac Death, Ventricular Fibrillation, Ventricular Tachycardia
Conditions
Keywords
ICD, CRTD, DF4
Brief summary
The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the DF4 Connector Systems. This study is conducted within Medtronic's post-market surveillance platform.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Subject is intended to be implanted or is within 30 days post-implant of a DF4 Connector System with a Medtronic DF4 lead used for a pacing, sensing and/or defibrillation application
Exclusion criteria
* Subject who is, or will be inaccessible for follow-up at a study site * Subject with
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DF4 Lead Related Complication Rate | Up to 5 Years | To demonstrate that the complication-free probability is greater than 92.5% at five years post-implant for the high voltage DF4 lead |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Types of DF4 lead related events | Up to 5 years | Number of DF4 lead related events grouped by type |
| Bipolar pacing impedance (ohms) | 5 years | Summary statistics at 5 years post-implant will be reported. |
| High voltage impedance (ohms) | 5 years | Summary statistics at 5 years post-implant will be reported |
| Pacing threshold (volts) | 5 years | The pacing threshold is the minimum electrical stimulus needed to consistently depolarize the heart outside of the heart's refractory period. Summary statistics at 5 years post-implant will be reported. |
| Sensing amplitude (millivolts) | 5 years | The amplitude of the intrinsic cardiac electrical signals detected by electrodes on the defibrillator lead will be summarized at 5 years post-implant. |
Countries
Canada, France, United States